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Axonal transport deficits have been reported as an early pathology in several
neurodegenerative disorders, including glaucoma. However, the progression and
mechanisms of these deficits are poorly understood. Previous work suggests that
anterograde transport is affected earlier and to a larger degree than retrograde transport,
yet this has never been examined directly in vivo. Using combined anterograde
and retrograde tract tracing methods, we examined the time-course of anterograde
and retrograde transport deficits in the retinofugal projection in pre-glaucomatous (3
month-old) and glaucomatous (9–13 month old) DBA/2J mice. DBA/2J-Gpnmb+ mice were
used as a control strain and were shown to have similar retinal ganglion cell densities as
C57BL/6J control mice—a strain commonly investigated in the field of vision research.
Using cholera toxin-B injections into the eye and FluoroGold injections into the superior
colliculus (SC), we were able to measure anterograde and retrograde transport in the
primary visual projection. In DBA/2J, anterograde transport from the retina to SC was
decreased by 69% in the 9–10 month-old age group, while retrograde transport was
only reduced by 23% from levels seen in pre-glaucomatous mice. Despite this minor
reduction, retrograde transport remained largely intact in these glaucomatous age groups
until 13-months of age. These findings indicate that axonal transport deficits occur in semi-
functional axons that are still connected to their brain targets. Structural persistence as
determined by presence of estrogen-related receptor beta label in the superficial SC was
maintained beyond time-points where reductions in retrograde transport occurred, also
supporting that transport deficits may be due to physiological or functional abnormalities
as opposed to overt structural loss.
Keywords: glaucoma, ocular, vision disorders, superior colliculi, optic nerve, neurodegeneration, axonal transport,
axonopathy
INTRODUCTION
The trafficking of molecules and organelles through the extensive
network of neuronal cell processes make neurons vulnerable in
many disease states. Axons, the major output processes of neu-
rons, often extend great lengths and end in synaptic boutons
that exhibit massive metabolic demands, protein turnover, and
signaling between the neuron and other cells. Nearly all neu-
ronal proteins are synthesized within the cell body and conveyed
along the axon through active axonal transport mechanisms.
Conversely, survival factors and proteins for degradation are
moved toward the cell body via retrograde transport. Axonal
transport is a tightly regulated process performed by molecular
motors in the kinesin or dynein family traveling along micro-
tubule tracks. Defects in axonal transport have been reported
as some of the earliest pathologies in neurodegenerative disor-
ders (Adalbert et al., 2009; Brady and Morfini, 2010), including
glaucoma (Anderson and Hendrickson, 1974; Minckler et al.,
1976, 1977; Crish et al., 2010).
Glaucoma is a group of neurodegenerative conditions that
together make up the leading cause of irreversible blindness
worldwide, estimated to affect 80million people by 2020 (Quigley
and Broman, 2006). Vision loss occurs from retinal ganglion cell
(RGC) dysfunction and neurodegeneration. Despite this, the only
treatments for glaucoma address a major risk factor, elevated
intraocular pressure, rather than the neural changes responsi-
ble for vision loss (see Osborne, 2009; Danesh-Meyer, 2011).
Despite increased interest, neuroprotective or neurorestorative
interventions remain elusive—mainly because of our relatively
poor understanding of the progression and mechanisms underly-
ing pathology (McKinnon et al., 2008). Interruption of transport
was originally attributed to constriction of the optic nerve head
as RGC axons exit the eye (Pease et al., 2000; Quigley et al., 2000),
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however, more recent work suggests subtler intra-axonal mech-
anisms play a major role in these pathologies (Crish et al.,
2010; review in Crish and Calkins, 2011). It has been sug-
gested that anterograde transport deficits precede retrograde
transport deficits in the progression of glaucomatous pathol-
ogy (Buckingham et al., 2008; Crish et al., 2010), but these
deficits have never been directly compared. Furthermore, it is
unknown how much of the retrograde transport deficits are due
to axon/terminal loss rather than dysregulation of axonal trans-
port machinery or similar issues. The precedence of anterograde
transport deficits suggests that there are specific, novel mech-
anisms related to cytoskeletal alterations or molecular motors
underlying the pathogenesis of glaucoma. Most importantly, this
indicates that an intact, semi-functional axon persists after the
onset of pathology—opening up new avenues of potential ther-
apies focused on restoring or protecting neuronal function rather
than replacing lost structure.
Using anterograde and retrograde tract tracing methods, we
examined the time-course of transport deficits in the retinofugal
projection in the DBA/2J mouse model of glaucoma. Anterograde
transport deficits were pronounced at 9–10 months of age,
whereas retrograde transport from the superior colliculus (SC)
to the retina remained largely intact until 13 months of age.
Structural persistence of the SC was maintained beyond time-
points where reductions in retrograde transport occurred, indi-
cating that transport deficits are likely due to physiological or
functional abnormalities as opposed to structural loss.
MATERIAL AND METHODS
ANIMALS
This study used mixed-sex DBA/2J (n = 27; 6–9 per age group),
DBA/2J-Gpnmb+ (n = 15), and C57BL/6J (n = 7) mice of dif-
ferent ages. The DBA/2J mouse has two loss of function muta-
tions that produce iris atrophy resulting in age-related elevation
of intraocular pressure (IOP) and a course of degeneration of
visual structures (John et al., 1998). Together, these character-
istics resemble ocular hypertension-induced structural changes
to the eye as seen in some forms of human glaucoma. DBA/2J-
Gpnmb+ mice have the same background as the DBA/2J, however,
they express a functioning wild type Gpnmb+ allele that prevents
them from developing elevated IOP or glaucomatous pathology
(Howell et al., 2007). Given the recent development of DBA/2J-
Gpnmb+ mice as controls for glaucoma (Howell et al., 2007;
Porciatti et al., 2010), we also used C57BL/6J mice as a com-
parison since the C57 strain has been commonly used as a
control strain in the visual system (Crish et al., 2010; Porciatti
et al., 2010). All animals were originally obtained from The
Jackson Laboratory (Bar Harbor, ME) and then housed and aged
in the Comparative Medicine Unit at Northeast Ohio Medical
University to the following time points. For the DBA/2J model,
we used 3 month old mice representing the pre-glaucomatous
ages, 9–10 month old mice representing ages at the onset of glau-
comatous pathology where anterograde transport deficits and
mild axonopathy are evident, 11–12 month old mice represent-
ing increasing transport deficits and axonopathy, and 13 months
where retrograde transport deficits along with axon and cell body
loss is evident (Buckingham et al., 2008; Crish et al., 2010).
For controls, we used C57BL/6J mice from a convenience sam-
ple that ranged in age from 4–17 months, and 9–13 month old
DBA/2J-Gpnmb+ mice—ages targeted for representing the onset
of significant glaucomatous pathology in the DBA/2J mice. Mice
were maintained in a 12 h light/dark cycle with standard rodent
chow available ad libitum. All mice were housed in the same room
under the same environmental conditions. The Northeast Ohio
Medical University Institutional Animal Care and Use Committee
approved all experimental procedures.
ANTEROGRADE TRANSPORT LABELING (INTRAVITREAL INJECTIONS)
Mice were placed prone in a stereotaxic device (Stoelting, Wood
Dale, IL) equipped with a nose cone set to deliver 2.5% isoflurane
at 0.8ml/min. Injections (1.5μl) of 1% cholera toxin subunit B
(CTB) conjugated to Alexa Fluor-488 (Invitrogen, Carlsbad CA)
in sterile phosphate buffered saline (PBS) were administered into
the vitreal chamber of each eye using a 33-ga needle attached
to a 25μl Hamilton syringe. Animals remained anesthetized in
the stereotaxic device for immediate surgical preparation for the
retrograde labeling procedure. CTB was used because it is selec-
tively taken up by RGCs (except in the cases of advanced retinal
pathology; Crish et al., 2010; Inman et al., 2012)—allowing us
to determine uptake and transport in the retina. Furthermore,
CTB has significant advantages over other commonly used trac-
ers for anterograde transport in that it travels along all axons
of the retinofugal projection and is visible in each component
(Angelucci et al., 1996).
RETROGRADE TRANSPORT LABELING (INTRACRANIAL INJECTIONS)
Surgical sites on the dorsal surface of the skull for mice
were cleaned and prepared for the craniotomy procedure.
Craniotomies (each 1mm2) to expose the surface of the brain
were drilled into each side of the skull using a 0.5mm
burr attached to a micro-motor drill. Two injection sites per
hemisphere were used to administer FluoroGold to the entire
rostro-caudal span of the SC and were delivered at the follow-
ing stereotaxic coordinates (each relative to bregma and sagittal
suture skull landmarks): −4.0mm anterior-posterior, ±0.5mm
medial lateral; and −4.4mm anterior-posterior, ±0.5mmmedial
lateral. At each craniotomy site, a 25μl Hamilton syringe
equipped with a 33-ga needle was lowered (via stereotaxic device)
at a 45◦ angle to a depth of 0.5mm below the skull surface.
This approach differs from previous studies (e.g., Buckingham
et al., 2008) in that it minimizes damage to the injection site
within the SC, allowing analysis of intact anterograde transport
from the retina and RGC marker labeling to determine struc-
tural persistence. Once at injection depth, 1μl of 3% FluoroGold
(FG) (Fluoro-Gold, Fluorochrome; Denver, CO) in 10% dimethyl
sulfoxide (DMSO)/PBS was injected. After each injection was
complete, the needle was retracted over 30 s. Sterile bone wax
was used to seal each of the skull openings and the incision site
was closed with tissue adhesive (Vetbond; 3M, USA). Animals
were allowed to recover for 72 h before sacrifice. FG was selected
as our retrograde tracer because it is the most commonly used
tracer for retrograde labeling of RGCs and it is taken up and
packaged passively (Wessendorf, 1991). As long as RGC structure
is present, FG is able to get inside the cell and into its vesicles.
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Any lack of FG-positive cell bodies seen in an intact projection
would be due to issues such as transport blockade or similar
deficits.
TISSUE COLLECTION AND PREPARATION
Seventy-two hours after injections, subjects received a single
intraperitoneal injection of 120mg/kg sodium pentobarbital and
were transcardially perfused with 4% paraformaldehyde in PBS
solution. This time frame was selected to allow both tracer appli-
cations to be performed at the same time—longer survival times
typically used for FG tracing have been reported to result in
loss of anterograde tracer in the retinofugal projection in a simi-
larly sizedmammal (Kahn and Krubitzer, 2002).While retrograde
transport is slower than the fast anterograde transport CTB uses,
this is still an adequate amount of time to cover the distances
needed. The brains, optic nerve, and eyes were harvested and
retinas were dissected from the eyes. Before histological prepa-
ration, the cortex overlying SC was removed and the brain was
photographed to determine FG placement. Failed FG injections
were identified by lack of tracer coverage of the majority of SC
surface and these projections were then excluded from analy-
sis (Abbott et al., 2014). Failed CTB injections were identified
by lack of tracer in the retina and these projections were also
excluded from analysis. Retinas were prepared as flattened whole-
mounts: four radial cuts were made in the surface, vitreous
humor was removed, and retinas were mounted nerve fiber layer
side up on slides. Slides were then covered with Fluoromount-
G mounting media (Southern Biotech; Birmingham, AL) and
cover-slipped.
IMMUNOHISTOCHEMISTRY FOR STRUCTURAL MARKERS
In order to assess whether axon loss was driving deficiencies in
transport from the SC, we stained for estrogen-related recep-
tor beta (ERRβ) which labels all components of retinal gan-
glion cells including their projection to the SC (Real et al.,
2008; Crish et al., 2010). Fiftyμm coronal serial slices through
the SC were taken using a freezing sliding microtome. Every
third section of the serial SC slices were added to a 96-well
plate containing 200μl (per well) block solution (5% donkey
serum, 1% Triton-X 100 in 1× PBS) for 2 h at room tem-
perature. Sections were then incubated in primary antibody
solution containing rabbit polyclonal antibody ERRβ (1:500,
Sigma-Aldrich, E0156; St. Louis, MO) in 3% donkey serum,
1% Triton-X 100 in PBS for 72 h at 4◦C, removed and washed
3× for 10min, and then incubated in Alexa Fluor-594 conju-
gated secondary antibody (1:200, JacksonImmunoresearch; West
Grove, PA) overnight at 4◦C. Sections were rinsed 3 × 10min
in PBS before being mounted on microscope slides, and cover
slipped with Fluoromount-G. Twentyμm sections of optic nerves
were taken parallel to their long axis and stained for the axonal
cytoskeletal proteins β-Tubulin (Covance, PRB-425P, 1:5000;
Greenfield, IN) and superphosphorylated heavy chain neurofil-
ament (pNF, Covance, SMI-310; Greenfield, IN). Secondary anti-
bodies used for these assays were donkey anti-rabbit Alexa Fluor-
594 conjugated (for β-Tubulin) or donkey anti-mouse Alexa
Fluor-647 conjugated (for pNF; Jackson ImmunoResearch, West
Grove, PA).
MICROSCOPY
Retina and sections containing SC were photographed with a
Zeiss AxioZoom V16 epifluorescent microscope equipped with
a digital high-resolution camera (AxioCam MRm Rev.3; Zeiss,
Jena, Germany) and a computer guided motorized Z and X-
Y stage. Retinal whole-mount reconstructions were obtained by
multi-frame acquisitions captured side-by-side with 10% overlap
with a 3.6×/0.50 objective (Plan-Neofluar, Zeiss, Jena, Germany)
at a final magnification of 160×. Each frame was Z-stacked at
an interval of 4–8μm, producing a stack between 5–10 images.
Multi-frame tiles were defined to cover the whole retina com-
pletely. Tiled images were aligned to eliminate overlap and create
a montage of the entire retinal surface using stitching software in
Zen Pro (Zeiss; Jena, Germany). Superior colliculi from each ani-
mal were imaged at 80× under multiple channels to capture label
from CTB and ERRβ. Optic nerves were imaged on an Olympus
FV-1000 confocal microscope (Olympus, Cedar Valley, PA).
MEASUREMENT OF RETROGRADE TRANSPORT
For analysis, Z-stack retina images were flattened into a single
layer TIFF using extended depth of focus (EDF) software in Zen
Pro. ImagePro (Media Cybernetics; Rockville, MD) software was
used to count FG-labeled RGCs in the retina using subroutines
similar to ones published by Salinas-Navarro et al. (2009a). In
brief, we applied a sequence of 2-D filters to each retinal image
that (a) defined and separated individual cells and (b) established
criteria for cell size boundaries and roundness and (c) removed
artifacts/noise. In order to calculate density of FG-labeled RGCs
in each retina, we used the ImagePro software to measure the area
of each retina. We divided the total number of FG-positive RGCs
counted in each retina by the total area of that retina to yield a
density measure of cells/mm2. To quantify sectorial loss of FG
labeling in retina characteristic of glaucomatous pathology, we
measured the area of sections within the retina where FG-positive
cells were absent. We subtracted these areas from the total area of
the retina to produce a value that represented total area of intact
FG and then divided the total area of intact FG by the total reti-
nal area to create the variable “percent area intact” for analysis
of intact retrograde transport. This variable was created to allow
direct comparison with deficits in the retinotopic collicular map.
MEASUREMENT OF ANTEROGRADE TRANSPORT AND STRUCTURE
We quantified CTB and ERRβ signal density in multiple slices of
the SC using a custom-written macro for NIH ImageJ (Rasband,
1997–2014). This macro performed the same function as the
techniques described in Crish et al. (2010) for quantifying sig-
nal density in the SC. We set background intensity for each SC
section by selecting a region of nonretinorecipient SC (layers
IV-VII) or periaqueductal gray for comparison with the retinore-
cipient SC. We outlined the retinorecipient layers of the SC using
layer IV as the ventral border and created bins of pixels running
from medial to lateral SC. The number of pixels within bins with
CTB or ERRβ signal brighter than background were divided by
the total number of pixels in the bin to provide either CTB or
ERRβ signal density at that location. We were able to visualize
anterograde transport deficits and structural loss in the collicular
retinotopic map by constructing colorimetric representations of
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CTB or ERRβ density [ranging from 0% (blue) to 100% (red)]
at each mediolateral location in the SC section and aligning them
using Origin Pro software (OriginLab; Northampton, MA). The
methods used to create these representations are adapted from
Crish et al. (2010) and the code for the ImageJ macro is freely
available upon request from the authors.
STATISTICAL ANALYSIS AND VARIABLES
We used two-way between-subjects factorial analyses of vari-
ance (ANOVA) with post-hoc Fisher’s Least Significant Difference
(LSD) tests to determine differences in transport between
strains/ages. To compare differences in magnitude between
anterograde, retrograde, and structural label within subjects for
each age group, we used paired t-tests to delineate the effects
of these planned comparisons. We also used one-way ANOVA
to assess control data and Pearson’s correlations for additional
descriptive measures. Retrograde transport was defined as either
FG-positive cell density in retina or percent area of intact FG
staining in retina. Anterograde transport was defined as percent
area fraction of intact CTB label in the SC contralateral to the
retina analyzed for retrograde transport. Additionally, the struc-
tural intactness of each SC was measured by percent area fraction
of intact ERRβ label. Retrograde and anterograde transport were
compared within the same projection. Each retina and corre-
sponding contralateral SC set were analyzed separately within
each animal, as glaucomatous pathology differentially affects
each eye thus necessitating the analysis of each projection as an
independent measure (Schlamp et al., 2006; Crish et al., 2010).
RESULTS
FG DENSITY DOES NOT DIFFER BY STRAIN OR AGE IN C57BL/6J AND
DBA/2J Gpnmb+ CONTROL MICE
FG-positive cell density in retina from C57BL/6J (C57) and
DBA/2J-Gpnmb (D2G) control strains were compared across age
groups to determine if the FG distribution pattern in D2G mice
matched that of C57s and if there was similarity between younger
and older controls. We compared the density of FG-positive cells
in the retina across C57 mice (age range 4–17 months) and D2G
mice (age range 9–13 months). Results of an ANOVA indicated
no significant differences between ages or strains, F(6, 22) = 1.18,
P = 0.365, ns (Figure 1). This validated our use of D2G control
mice as a comparable (and more background relevant) substitute
for the C57 control strain. Additionally, as these numbers are sim-
ilar to other studies using FG to label RGCs (e.g., Buckingham
et al., 2008), this validated our modified method of FG appli-
cation. Furthermore, this is the first reported analysis of FG
transport in D2G mice. For the remaining analyses, we pooled
the D2G control data across ages where we typically see glauco-
matous pathology in the DBA/2J (9–12 months old) to form a
single control group for this strain.
MAJOR FINDINGS
The following abbreviations will be used to label the DBA/2J
age groups represented by our data: D3 (3-month old DBA/2J),
D9-10 (9–10 month old DBA/2J), D11-12 (11–12 month old
DBA/2J), and D13 (13-month DBA/2J). Figure 2 shows examples
of tracing in whole mount brain (cortex removed) and retina.
FIGURE 1 | FluoroGold (FG) density in the retina across age and
control strains. Mean FG-positive cell density (cells/mm2) in the retina is
shown on the y-axis; age and strain are shown on the x-axis. C57BL/6J
(C57) ranged in age from 4 to 17 months old (mo.). DBA/2J Gpnmb+ (D2G)
mice ranged in age from 9–13 mo. There were no significant differences in
mean FG density in the retina between strains or ages [ANOVA:
F(6, 22) = 1.18, P = 0.365, ns]. Number of cases per group are shown in
parentheses. Error bars show standard error of the mean for each group.
The left panel in row A shows clear anterogradely-transported
CTB label in the major retinal targets (lateral geniculate nucleus,
pretectum, and SC) and the right panel in row A shows good cov-
erage of the SC with FG. Row B (left) shows a near complete loss
of CTB in the left SC and nearly no loss on the right (right panel,
row B). FG covers the SC completely. Row C illustrates the range
of retrograde transport of FG we found, from complete coverage
in the leftmost panel, to sectorial loss in the middle panel, and a
near complete loss in the rightmost panel.
In D2G (Figures 3A,B) and young DBA/2J (D3) mice (data
not shown), uniform CTB and ERRβ were evident in superficial
SC. Colorimetric reconstructions of the entire SC demonstrated a
uniformly dense labeling (indicated by red/orange/yellow colors)
across the entire SC (Figures 3C,D). In aged DBA/2J mice, reduc-
tions in CTB label were often found (Figures 3E,I,M,O). Deficits
in the SC occurred in sectorial patterns, with some areas devoid of
CTB (indicated by blue/green color) and some with strong label
(Figure 3G). In DBA/2J mice up to 12 months of age, RGC struc-
tural marker ERRβ appeared normal even in colliculi with severe
CTB loss (compare Figures 3F,H with E,G; also J,L with I,K). In
13-month DBA/2J mice we saw significant loss of ERRβ label as
well (Figures 3N,P).
As seen previously (e.g., Crish et al., 2010), lack of CTB label
in the SC is not due to loss of RGC somata or axons. CTB-positive
RGCs and axons are readily visible in whole mount retina—even
in projections with complete absence of collicular CTB (Figure 4,
first column). Dense concentrations of FG-positive RGC somata
(FG is not typically visible in axons) are also obvious in all
but some of the oldest animals studied here (Figure 4, second
column). Examination of the optic nerves show persistence of
CTB-positive axons in the distal-most portions of this struc-
ture (Figure 4, third column). Interestingly, these axons appear
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FIGURE 2 | Examples of tracing in whole mount brain (cortex
removed) and retina. (A) left: shows clear anterogradely-transported
CTB label in the major retinal targets that include lateral geniculate
nucleus (LGN), pretectum (PT), and superior colliculus (SC), other
identifying landmarks outside the visual pathway include inferior colliculus
(IC) and cerebellum (Cb). (A) right: shows good coverage of the SC with
retrograde tracer FluoroGold (FG). (B) left: shows a near complete loss
of CTB in the left SC and nearly no loss in the right SC. (B) right: FG
covers the SC completely. (C) Illustrates the range of retrograde
transport of FG we found, from complete coverage in the leftmost
panel, to sectorial loss in the middle panel, and a near complete loss in
the rightmost panel.
to have altered levels of cytoskeletal proteins. In contrast to D2G
control mice, β-tubulin levels in the optic nerve of DBA/2J mice
appear reduced whereas pNF is increased in mice with significant
transport deficits (Figure 4, Tub & pNF columns). At advanced
pathological stages where ERRβ loss is seen, β-tubulin and pNF
are substantially reduced, indicating axon degeneration (Figure 4,
bottom row).
In order to quantitatively compare intact retrograde trans-
port (FG), anterograde transport (CTB), and structure (ERRβ)
for each group of mice as well as compare how these val-
ues changed as a function of age in the DBA/2J mice, we
used a 3 (CTB, FG, ERRβ) by 5 (D2G, D3, D9-10, D11-12,
D13) factorial ANOVA for analysis. Significant main effects for
label [F(2, 104) = 29.98, P < 0.001] and strain/age [F(4, 104) =
91.57, P < 0.001] were shown. A significant interaction between
type of label and strain/age group qualified these main effects
[F(8, 104)= 8.64, P < 0.001]. Post-hoc Fisher’s LSD tests were
used to define the significant pairwise comparisons as described
below.
ANTEROGRADE, RETROGRADE, AND STRUCTURAL LABEL DO NOT
DIFFER BETWEEN D2G CONTROLS AND 3-MONTH OLD DBA/2J MICE
As anticipated, there were no significant differences in intact
anterograde (P = 0.808, ns), retrograde (P = 0.8310, ns), or
structural label (P = 0.943, ns) between D2G controls and D3
(pre-glaucomatous) mice (Figures 5A–C). Therefore, we only
report post-hoc pairwise comparisons between the DBA/2J age
groups.
ANTEROGRADE TRANSPORT (CTB) IN SC IS SIGNIFICANTLY REDUCED
AT 9-MONTHS OF AGE IN DBA/2J MICE
Glaucomatous DBA/2J (D9 and older groups) showed a marked
reduction in CTB label in the SC compared to the D3 group
(Figure 5A). The D3 group had significantly more intact label
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FIGURE 3 | Differential transport loss with structural persistence in the
superior colliculus (SC) of mice. The first two columns are cross-sections
through the midbrain showing the superior colliculus. (A,B) Robust CTB and
ERRβ label were evident in superficial SC of a control D2Gmouse at 12months
of age. (C,D) are colorimetric reconstructions of the entire SC, warmer colors
are denser with red representing 100% of the pixels at that location positive for
either CTB (C) or ERRβ (D). As expected, this colliculus demonstrates a
uniformly dense labeling across the entire SC. In aged DBA/2Jmice, reductions
in CTB label were often found (E,I;G,K). These deficits occurred in sectorial
patterns, with some areas devoid of CTB (represented by blue) and some with
strong label (right side ofG). In DBA/2J mice up to 12 months of age, retinal
ganglion cell (RGC) structural marker ERRβ appeared normal even in colliculi
with severe CTB loss (F,J; H,L). In 13-month DBA/2J mice we saw significant
loss of ERRβ label (N,P) along with absence of CTB label (M,O).
than D9-10, D11-12, and D13 (Fisher’s LSD P < 0.001 in all three
comparisons). Fisher’s LSD tests indicated that there were no dif-
ferences in CTB label between the three oldest DBA/2J groups
(D9-10 vs. D11-12: P = 0.545, ns; D9-10 vs. D13: P = 0.098, ns;
D11-12 vs. D13: P = 0.219, ns).
STRUCTURE OF SC (ERRβ) REMAINS INTACT UNTIL 13 MONTHS OF
AGE IN DBA/2J
The persistence of RGC axon terminals (percent intact ERRβ) in
the SC did not differ between D3 and D9-10 (Fishers LSD; P =
0.978, ns), D3 and D11-12 groups (P = 0.088, ns), or between
D9-10 and D11-12 groups (P = 0.094, ns). ERRβ was signifi-
cantly reduced in the 13-month old DBA/2J mice in contrast to
D3, D9-10, and D11-12 groups (Fisher’s LSD; P < 0.001 in all
comparisons; Figure 5B).
FG DENSITY AND PERCENT AREA OF INTACT FG IN RETINA ARE
CORRELATED
Other studies of retrograde transport use FG-positive cell density
in the retina as the primary measure of transport (see for exam-
ple Buckingham et al., 2008). However, to perform within-animal
comparisons between retrograde and anterograde transport, we
established a variable that allowed direct comparison of FG in
the retina with percent area fraction of CTB and ERRβ in the
SC. Using montaged image tiles of the entire retinal surface (See
Figure 2, bottom row), we quantified the percent area of intact
FG label as well as FG-positive cell density in the same retina for
all our mice and found that these variables were highly corre-
lated (Pearson’s r = 0.80, P < 0.0001; Figures 5C,D). Therefore,
we used percent area intact FG in the retina to compare retrograde
label with anterograde and structural labels.
RETROGRADE TRANSPORT (FG) IN THE RETINA IS SLIGHTLY REDUCED
AT 9-MONTHS BUT IS LARGELY INTACT COMPARED TO ANTEROGRADE
TRANSPORT
In contrast to our pre-glaucomatous D3 mice, the percent area
of intact FG was significantly reduced in the D9-10 group
(Figure 5C) (Fisher’s LSD; P = 0.02), D11-12 group (P < 0.001),
and D13 group (P < 0.001). Intact retrograde transport levels
were similar between the D9-10 and D11-12 groups (P = 0.312,
ns), but showed a further reduction in the D13 age group (Fisher’s
LSD; P < 0.001 in both sets of comparisons).
We used paired t-tests to assess within-subject differences
in the magnitude of CTB, FG, and ERRβ label for each age
group of animals tested. In both the D2G control and D3
groups, there were no measurable differences in the magnitude
of label between anterograde, retrograde, and structural mark-
ers. However, in the D9-10 group, the amount of intact FG was
significantly greater than CTB, t(5) = 2.35, P = 0.03 (Figure 6).
This difference was maintained in the D11-12 group [t(8) =
3.059, P = 0.02] before dropping to comparable levels in the D13
group.
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FIGURE 4 | Retina and optic nerve of three 12-month mice. (A)
Representative images of whole mount retina showing CTB uptake and
transport in retinal ganglion cells (RGCs). Insets are collicular CTB maps;
red represents 100% of the pixels at that location positive for CTB,
blue is no label. Top row: Control D2G mice with normal anterograde
and retrograde transport. Dense CTB label is evident in RGC somata
and axons, and retrogradely FluoroGold (FG) labeled RGCs are readily
visible. Middle row: 12-month old DBA/2J with significant loss of CTB
but ERRβ persistence. Despite a near complete loss of anterograde
transport of CTB to the superior colliculus (inset), RGCs in the
corresponding retina still take up and transport the CTB and FG tracers.
Bottom row: 12-month old DBA/2J with advanced pathology—complete
loss of both CTB and ERRβ in the SC. RGCs are still present and
taking up/ transporting CTB within the retina. There is a loss of
retrogradely transported FluoroGold (FG) in the retina. (B) Corresponding
optic nerves near the optic chiasm. CTB is readily apparent in axons
even in animals lacking collicular CTB (middle and bottom rows). The
second row contains some “string of pearls” varicosities indicative of
intra-axonal transport blockades as indicated by arrowheads. The
projection with the most severe pathology (bottom row) contains large
end-bulbs indicative of dying-back or distal Wallerian degeneration.
β-Tubulin (Tub) labeling was lower in the DBA/2J mice with anterograde
transport deficits (middle and bottom rows). Superphosphorylated
heavy-chain neurofilament (pNF) labeling was increased in animals with
selective anterograde transport deficits (middle row) and reduced in
animals with severe deficits in both forms of transport (bottom row).
STRUCTURAL INTEGRITY OF THE SC IS MAINTAINED BEYOND
RETROGRADE TRANSPORT LOSS
Normal collicular ERRβ label persisted through 12 months
of age as shown in Figure 5B and was significantly greater
than retinal FG label in the D9-10 [t(5) = −3.41, P = 0.02]
and D11-12 [t(8) = 3.85, P = 0.005] groups (Figure 6). Along
with the previous data on CTB label magnitude, this find-
ing indicates that the structure of the SC and some com-
ponents of the RGC projection remained intact after both
forms of transport showed significant deficits. In the oldest
age group (D13), both forms of transport showed over 90%
deficits in intact label with a corresponding 86% reduction in
ERRβ. Although structural label was not maximally lost, ERRβ
and the transport labels did not differ significantly at D13
(Figure 6).
Differential reductions in transport by individual projections
are summarized in Figure 7. The top plot compares anterograde
(CTB) and retrograde (FG) transport in the same projection. We
have plotted a unity line where we would expect the points to fall
if both forms of transport were similarly affected. Supporting our
group observations, we have a significant cluster of cases below
the unity line, indicating that we saw much larger anterograde
deficits than retrograde deficits at younger ages. As shown in the
bottom plot of Figure 7, when we compared retrograde transport
to our RGC projection structural marker in the SC (ERRβ) we
found a significant cluster of cases above the unity line, indicating
FG transport deficits precede loss of ERRβ immunoreactivity in
the SC.
DISCUSSION
Both anterograde and retrograde transport have not been pre-
viously assessed within the same projection—primarily due to
technical limitations of the surgeries used for FG application.
Historically, FG application required one or more large injec-
tions into the SC followed by intracranial insertion of FG-soaked
pledgets for additional tracer exposure (see Sellés-Navarro et al.,
1996; Villegas-Pérez et al., 1996). This method resulted in exten-
sive damage to the SC, precluding analysis of the RGC projection,
anterograde transport levels, or FG exposure in this structure
(Buckingham et al., 2008; Soto et al., 2008). Therefore, we modi-
fied the number, size, and approach of our intracranial injections
to achieve complete uptake and transport to the retina while
preserving the structure of the SC for immunohistochemical
analysis.
Using tract tracing of the central visual pathway within the
same projection, we found that severe deficits in anterograde
transport appeared at an earlier age than deficits in retrograde
transport (Figures 5, 6). Anterograde transport is reduced by
almost 70% at 9–10 months of age which is comparable to (and
statistically indistinguishable from) the near-maximal 92% loss
in label shown at 13-months. This is a 3-fold greater reduc-
tion in label than was seen with retrograde transport, which, at
9–10 months was only reduced by 23%. Additionally, retrograde
transport remained largely intact until 13-months where it then
dropped off to values comparable to anterograde transport—
a finding consistent with other published reports that assessed
retrograde transport in DBA/2J (Buckingham et al., 2008). This
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FIGURE 5 | Intact label across strains/age groups. (A) Mean percent
area fraction of intact CTB (anterograde) label and (B) ERRβ (axon
terminal) label in the superior colliculus (SC). (C) Mean percent area
of intact FluoroGold (FG; retrograde) label in the retina. No significant
differences in any of the three labels were shown between
DBA/2J-Gpnmb+ (D2G) control and 3-month old (mo.) DBA/2J mice
(CTB: P = 0.808, ns; ERRβ: P = 0.943, ns; FG: P = 0.831, ns). (A)
CTB was significantly reduced in 9–10 mo., 11–12 mo., and 13 mo.
animals compared to 3-mo. DBA/2J (P < 0.001 in all cases). (B)
Significant reduction in ERRβ label is only seen in 13-mo. DBA/2J
mice. (C) FG label was significantly reduced in 9–10 mo. (P = 0.02)
and 11–12 mo. (P < 0.001) mice compared to 3-mo. DBA/2J. FG label
in the D13 group decreased significantly from the 11–12 mo. group
(P < 0.001). (D) Mean density (cells/mm2) of FG-positive cells in the
retina. Results of analyses using FG density variable recapitulate
results using percent intact variable shown in (C). Mean FG density
and percent area intact FG variables are correlated, r = 0.80,
P < 0.001. The number of cases per group are as follows: D2G = 8;
DBA/2J 3-mo. = 6, 9-mo. = 6, 11–12 mo. = 9, and 13-mo. = 6.
Asterisks and brackets indicate statistically significant differences
between specific groups. Error bars show standard error of the mean
for each group depicted.
addresses one of the most important open questions raised by
previous studies examining these subjects (Buckingham et al.,
2008; Crish et al., 2010). Together these data indicate that the
RGC axonal projection remains at least semi-functional after
anterograde transport loss in glaucoma.
Our results are consistent with other studies that have exam-
ined these forms of transport separately in rodent glaucoma
models. In the DBA/2J mouse, anterograde transport deficits have
been shown at 8–10 months of age with pervasive loss by 12-
months while RGC axons and presynaptic terminals in the SC can
persist up to 18 months (Crish et al., 2010; Dapper et al., 2013).
Retrograde transport deficits have been observed to occur later
around 13 months (Buckingham et al., 2008; Salinas-Navarro
et al., 2009b; Vidal-Sanz et al., 2012). These findings address a
secondmajor question from these original studies, indicating that
retrograde transport loss occurs before overt loss of structure in
the projection. This suggests previously postulated mechanisms
such as intra-axonal cytoskeletal abnormalities, motor protein
issues, or metabolic deficits likely play a large role in the transport
deficits seen in this model (Baltan et al., 2010; Crish et al., 2010;
Crish and Calkins, 2011). Collectively, these findings indicate that
axonal transport deficits are pre-degenerative and may be differ-
entially impaired in glaucoma. This data is consistent with results
found in other neurodegenerative conditions (Lafuente Lopez-
Herrera et al., 2002; Avilés-Trigueros et al., 2003; Morfini et al.,
2009b; Crish and Calkins, 2011).
We assessed the percent area of intact retina by measuring the
areas of absent FG and subtracting this from the overall retinal
area.We found this variable to be highly correlated with density of
FG-positive RGCs—however, it is important to note this percent-
intact variable fails to take into account any possible reductions
in the density of those intact areas. It is possible that subtle reduc-
tions in RGC density of those “intact” areas could show further
deficits in our studies. However, given the sectorial nature of
the deficits seen in glaucoma (Jakobs et al., 2005), and that the
DBA/2J mice we analyzed were of ages representing high likeli-
hood of pathology, it is unlikely these subtle differences would
have influenced our results.
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FIGURE 6 | Mean percent intact CTB (anterograde tracer), ERRβ (axon
terminal label), and FluoroGold (FG; retrograde tracer) label shows
respective loss of each tracer within age groups.Within-subjects’
statistical analyses showed that there are no differences in the amount of
each label in the DBA/2J-Gpnmb+ (D2G) control and 3-month old (mo.)
pre-glaucomatous DBA/2J groups (Paired t-test: P = ns in all cases). Retinal
retrograde (FG) label was significantly more intact than collicular anterograde
CTB label in glaucomatous DBA/2J at 9–10 mo. (P = 0.03) and 11–12 mo.
(P = 0.02). ERRβ label remained significantly more intact than FG label in
DBA/2J mice at 9-10 mo. (P = 0.02) and 11–12 mo. (P = 0.005). There were
no differences in themagnitude of intact label betweenCTB, ERRβ, and FG by
13-mo (P = ns). Asterisks and brackets indicate statistically significant
differences between specific groups. Number of cases per group are shown
in parentheses. Error bars show standard error of the mean for each group.
TRANSPORT FUNCTION IN GLAUCOMA
Impaired movement of cargo along the axon initiates several
degenerative mechanisms including distalWallerian degeneration
and apoptosis due to neurotrophin deprivation (see Coleman,
2005). There are a large number of possibilities that can neg-
atively affect proper transport function, including modification
of molecular motors, cytoskeletal disruption, and metabolic dys-
function (Coleman, 2005; Shea and Chan, 2008; Morfini et al.,
2009a; Crish and Calkins, 2011). These changes can often affect
very specific parts of transport such as different compartments of
the axon or the direction of cargo movement away from the cell
body or toward the cell body (Shea and Beaty, 2007). Due to the
complexity of the nervous system, most of the evidence report-
ing differential transport effects in pathology are ex vivo (see for
example, Brady et al., 1990; Morfini et al., 2007; Motil et al., 2007;
Lee et al., 2011; LaPointe et al., 2013).
Differential transport loss in glaucoma may be due to greater
sensitivity of anterograde transport to an intra-axonal block-
ade (Wang et al., 1995; Ross et al., 2006; see discussion in Shea
and Beaty, 2007). These intra-axonal blockades may result from
the disorganization and breakdown of the cytoskeleton with the
consequential accumulation of protein cargo (Shea et al., 2004;
Coleman, 2005; Crish et al., 2010). Dynein, the molecular motor
thatmediates retrograde transport, has greater lateral and bidirec-
tional movement along microtubules within the axon. Therefore,
dynein may more easily navigate around these blockades by
translocating to other, intact microtubule tracks at that loca-
tion. In contrast, the molecular motor that drives anterograde
FIGURE 7 | (A) Percent area of intact anterograde transport (CTB; y - axis) in
the superior colliculus (SC) in comparison with percent area of intact
FluoroGold (FG; x - axis) in the retina for individual projections. We have
plotted a unity line (slope = 1) where points would be expected to fall if the
percent of intact anterograde and retrograde transport changed similarly
across age groups. Only the fully intact (DBA/2J-Gpnmb+ (D2G) and 3-mo.
DBA/2J) and extremely pathological (13-mo. DBA/2J) cases fall along this
line. The majority of 9–10 mo. old and 11–12 mo. old DBA/2J cases fall well
below the unity line, indicating that CTB transport is diminished across
these age groups while retrograde remains intact. (B) Percent area of intact
axon terminals/structure (ERRβ; y-axis) in the SC vs. percent area of intact
retrograde transport (FG; x - axis) in the retina for individual projections. We
have plotted a unity line (slope = 1) where points would be expected to fall
if percent of intact retrograde (FG) transport in the retina and structural
integrity of the superior colliculus (ERRβ) changed similarly across age
groups. In contrast to CTB data, we find that the majority of 9–12 mo.
DBA/2J cases fall above the unity line, indicating that ERRβ remains intact
across more ages than does FG.
transport, kinesin, does not have this capability, therefore mak-
ing it vulnerable to axonal blockade (Wang et al., 1995; Ross et al.,
2006).
Additionally, the differential effects we have shown on axonal
transport may result from regulation of the molecular motors
themselves. Kinesin can be dysregulated or inhibited by kinases
such as GSK-3β, p38, and JNK, and activity of these kinases is
notably increased in neurodegenerative disorders (see Brady and
Morfini, 2010; Wang et al., 2014 for discussions). Notably, p38
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has recently been implicated in axonal transport deficits and dis-
tal axonopathy in DBA/2J mice (Dapper et al., 2013), JNK is
rapidly upregulated after RGC injury (Fernandes et al., 2014), and
investigations into GSK3β signaling pathways are ongoing in our
laboratories.
A common hypothesis in glaucoma is that axonal transport
is blocked by mechanical compression of the optic nerve head
(ONH) where the RGC axons leave the eye. If this were the case
then we would expect anterograde and retrograde transport to
be similarly affected, but here in the DBA/2J mouse they are not.
Furthermore, our observations of reduced levels of β-Tubulin
and increased levels of pNF support the idea that axon transport
is blocked by intra-axonal changes far removed from the ONH.
Both microtubule breakdown and abnormal phosphorylation of
neurofilaments have profound effects on axonal transport and
changes to both these proteins may play a large role in the deficits
seen here (Shea and Beaty, 2007). These intra-axonal changes may
also result from disruptions in kinase signaling pathways (Wang
et al., 2014). Even in extreme cases of CTB and ERRβ loss in
the SC, CTB-positive axons, varicosities, or end bulbs are evi-
dent in the optic nerve and tract as shown in Figure 4 as well
as in previous studies (Crish et al., 2010). This indicates that
these axons (even one undergoing distal axonopathy as shown
in Figure 4, bottom row) are still connected to their cell bod-
ies in the retina. It is important to note that this idea does not
detract from the role of the ONH in the development and pro-
gression of glaucoma—critical observations regarding the onset
of pathological change have been noted in the ONH and the
retina—and pathology in neurons (e.g., blocked axon transport
and axonopathy in this region) is often far-removed from the
site of the stressor (Conforti et al., 2007; Cuchillo-Ibanez et al.,
2008).
STRUCTURAL PERSISTENCE OF THE SC
Structural persistence of the RGC projection to the SC (as mea-
sured by intact ERRβ) was maintained in glaucomatous mice
from 9 to 12 months of age and significant decreases in ERRβ
label were only first measured at 13-months of age. Contrasting
with both anterograde and retrograde labels that first showed sig-
nificant reductions in the 9–10 month age group, our findings
suggest that transport deficits are likely due to physiological or
functional abnormalities as opposed to overt structural loss. Our
results did differ from previous reports of Crish et al. (2010) in
that our ERRβ label for intact SC was significantly reduced at 13-
months, whereas significant reductions in ERRβ did not appear in
those studies until 15–22 months. However, there is a significant
amount of variability in structural persistence beyond 12 months
of age (Crish et al., 2010) and it is possible that our smaller sam-
ple size of dual-traced animals captured more extreme deficit in
ERRβ at 13-months. However, this does not affect our overall
conclusions.
CYTOSKELETAL ALTERATIONS, NEURONAL SIGNALING, AND
TRANSPORT DEFICITS
Breakdown or modification of cytoskeletal elements or motor
proteins are common pathologies in neurological disorders such
as Alzheimer’s Disease and amyotrophic lateral sclerosis and can
negatively affect neuron structure and function in terms of cel-
lular integrity, axonal transport, and signaling (Coleman, 2005;
Conforti et al., 2007; Cuchillo-Ibanez et al., 2008; Shea and Chan,
2008; Morfini et al., 2009a; Shea et al., 2009). It is possible that
disruptions in axonal transport shown in our current studies
result from intra-axonal blockades caused by aberrant cytoskele-
tal organization/breakdown or dysregulation ofmolecularmotors
that may reflect changes occurring in glaucoma occurring before
overt degeneration of axons or cell bodies. A major question this
research raises is what is the connection between these changes
and other early pathologies seen in glaucoma? While anterograde
transport interruptions can drive axonal degeneration distal to
the blockage (see Coleman, 2005), the relationship between these
deficits and early dendritic remodeling in the retina (Jakobs et al.,
2005; Della Santina et al., 2013), inflammation (Bosco et al.,
2011), and physiological deficits in RGC activity (Della Santina
et al., 2013; see Saleh et al., 2007 for DBA/2J; Banitt et al.,
2013 for humans) or action potential conduction (Baltan et al.,
2010) remain to be determined. Inflammation as measured by
increased microglial number and activation occurs quite early in
the DBA/2J inner retina and ONH, peaking by 3 months (Bosco
et al., 2011). Since microglial release of NO can halt anterograde
axon transport (Stagi et al., 2005), there may be a negative impact
of these cells on axon transport quite early, though undetected
at 3 months in our study. The significant decreases in pattern
electroretinogram (PERG) amplitude that affect the DBA/2J by 6
months of age (Saleh et al., 2007) suggest changes in inner retina
activity that may be carried over into optic nerve as decreases in
compound action potential amplitude, an observation made in
DBA/2J mice with high IOP by 6 months of age (Baltan et al.,
2010). Alternatively, decreases in axon transport of mitochon-
dria in the DBA/2J optic nerve, for example, could also explain
loss of compound action potential amplitude. Our study focused
on transport changes very early (3 months) and late (9 months
and beyond), so additional analysis of anterograde axon trans-
port in between may be able to distinguish among the competing
mechanisms for the transport pathology observed. Such informa-
tion may provide exciting new avenues for treatments targeted at
restoring function and substructure in glaucomatous projections
that still remain largely intact.
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